PANWJune 2, 2026 at 8:20 PM UTCSoftware & Services

Palo Alto Networks Surges 12% on Q3 Beat and Upbeat Guidance; AI Security Tailwinds in Focus

Read source article

What happened

Palo Alto Networks reported fiscal Q3 earnings that beat Wall Street expectations, driven by strong demand for its cybersecurity platforms and AI-driven security solutions. The company's revenue and earnings exceeded estimates, and management provided rosy guidance for the upcoming quarter, citing sustained momentum in platform consolidation and the rise of advanced AI threats. Shares jumped 12% as investors cheered the results, which validated the company's strategy of expanding into AI security through products like Prisma AIRS and the pending acquisition of Portkey. However, the stock still trades at a lofty valuation (P/E ~129), and the DeepValue report maintains a WAIT rating, noting that the integration of CyberArk and Chronosphere has yet to prove earnings accretion. The key metric to watch remains RPO growth, which stood at $16B in Q2 and is guided to $20.2-20.3B for FY26—any deceleration would undermine the platform thesis.

Implication

The Q3 beat and guidance raise hopes that PANW can sustain its platform momentum, but the stock's 12% surge already prices in much of the optimism. The DeepValue report's WAIT rating remains appropriate, as the bull case hinges on CyberArk and Chronosphere delivering cross-sell benefits without margin erosion—evidence that won't be clear until late FY26 or early FY27. For existing holders, the pop is a chance to trim if the stock approaches the $300 trim-above level; new buyers should wait for a pullback near the $205 attractive entry. The key risk is that RPO growth decelerates below 15% YoY, which would break the platform consolidation thesis and could send the stock back toward $180. If PANW demonstrates continued RPO growth above 20% and early CyberArk attach rates, the bull case to $320 becomes viable, but that is not yet proven.

Thesis delta

The Q3 beat does not change the fundamental risk-reward calculus; the stock still trades above the DeepValue fair value range, and the integration of major acquisitions remains unproven. The thesis remains WAIT until there is concrete evidence of CyberArk synergy or a more attractive entry price.

Confidence

Medium